Lamisil Cream 1% Tb 15g

Lamisil Creme 1 % Tb 15 g

Brand: GSK CONS. HEALTHC. AG
Product Code: 1538776
Availability: 150
29.92 USD Price in reward points: 3211
Add to Cart
Add More for Bigger Discounts! Details

Buy 2 and save -1.20 USD / -2%


Description

Lamisil cream is a medicine for the treatment of fungal infections of the skin caused by filamentous fungi, such as athlete's foot, superficial skin fungal diseases, pityriasis versicolor. The cream is also effective against fungal infections caused by yeasts (skin candidiasis). General symptoms such as itching, scaling and redness subside under treatment with Lamisil. Most patients with athlete's foot showed no recurrence 2 months after a 1-week treatment with Lamisil.

Swissmedic-approved patient information

Lamisil CremeGSK Consumer Healthcare Schweiz AG

What is Lamisil Creme and when is it used?

Lamisil Creme is a medicine for Treatment of fungal infections of the skin caused by filamentous fungi, such as athlete's foot, superficial skin fungal diseases, pityriasis versicolor. The cream is also effective against fungal infections caused by yeasts (skin candidiasis). General symptoms such as itching, scaling and redness subside under treatment with Lamisil. Most patients with athlete's foot showed no recurrence 2 months after a 1-week treatment with Lamisil.

What should be considered?

To prevent fungal infections, you should follow a few rules:

  • Change clothing that comes into contact with the diseased skin every day.
  • Avoid tight-fitting clothing that is not very permeable to air.
  • Dry the skin carefully after washing.
  • Change towels every day.
  • If you have athlete's foot, do not go barefoot, sprinkle stockings and shoes with a powder that is effective against fungal infections or spray them with a spray every day.
  • Hands wash well after use and after contact with the affected skin. This can prevent the fungal infection from spreading further.

When should Lamisil cream not be used?

Lamisil should not be used if you are hypersensitive to the active ingredient terbinafine or one of the excipients it contains.

Lamisil cream has not been tested for use in children under 12 years of age. The use of Lamisil cream in children under 12 years of age is not recommended due to a lack of clinical experience.

When should you be careful when using Lamisil Cream?

Lamisil Cream is for external use only; the cream must not get into the eyes. If the preparation comes into contact with the eyes, the eyes must be rinsed out immediately with running water. Consult your doctor if the symptoms do not go away.

Lamisil cream contains cetyl and stearyl alcohol, which can cause local skin reactions.

Your doctor should be consulted in the event of extensive fungal infestation or joint infestation of the nails.

Do not apply other medicines to the treated skin.

Tell your doctor, pharmacist or druggist if you

  • suffer from other diseases,
  • have allergies or
  • take other medicines (including those you bought yourself!) or use them externally.

Can Lamisil Creme be used during pregnancy or breastfeeding?

Pregnancy

During pregnancy Lamisil Creme may be used not to be used unless specifically prescribed by a doctor. If you are planning a pregnancy, you should only use Lamisil after consulting a doctor.

Breastfeeding

Lamisil cream should not be used while breastfeeding. Small children must not come into contact with the treated skin areas.

How do you use Lamisil cream?

Before using Lamisil, thoroughly clean the affected skin with a cotton ball and warm water and dry it.

Adults and children over 12 years of age:

Lamisil Cream can be applied once or twice a day - in the morning and/or in the evening. Lamisil cream must be applied thinly to the diseased and adjacent areas of skin and rubbed in gently.

Usual treatment regimens:

Athlete's foot, superficial skin fungal diseases: 1 time per day for 1 week.

Athlete's foot of the "moccasin" type (athlete's foot on the soles and edges of the feet): 2 times a day for 2 weeks.

Fungal infections caused by yeast: 1 to 2 times a day for 1 week.

Pityriasis versicolor: 2 weeks 1 to 2 times a day.

In order to avoid recurrence, stick to the stated duration of use. If there are no signs of improvement after 1 week, a doctor should be consulted.

Follow the dosage given in this leaflet or as prescribed by your doctor. If you think the medicine is too weak or too strong, talk to your doctor, pharmacist or druggist.

What side effects can Lamisil cream have?

The following side effects can occur when using Lamisil cream:

Common side effects include flaking and itching. Occasionally skin irritation, pigmentation disorders, redness, burning sensation on the skin, pain or irritation at the application site can occur. Dry skin and eczema are rare.

If Lamisil accidentally comes into contact with the eyes, eye irritation may occur (see «When should you be careful when using Lamisil?»)

Stop using Lamisil and tell your doctor straight away if you get any of the following symptoms, which may be signs of an allergic reaction:

  • Trouble breathing or swallowing
  • Swelling of the face, lips, tongue or throat
  • Intense itching of the skin with a red rash or blisters.

If you notice side effects that are not described here, you should inform your doctor, pharmacist or druggist.

What else needs to be considered?

Keep out of the reach of children. Store in the original packaging at 15-30 °C. The medicinal product may only be used up to the date marked “EXP” on the package.

Your doctor, pharmacist or druggist can provide you with further information. These people have the detailed information for specialists.

What does Lamisil cream contain?

1 g cream contains 10 mg terbinafine hydrochloride (active ingredient), cetyl alcohol, stearyl alcohol, benzyl alcohol and other excipients .

Approval number

51307 (Swissmedic).

Where can you get Lamisil Cream? What packs are available?

In pharmacies and drugstores without a doctor's prescription.

Lamisil cream, 15 g tube.

Authorization holder

GSK Consumer Healthcare Schweiz AG, Risch.

This leaflet was last checked by the drug authority (Swissmedic) in June 2014.